| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/19/2005 | EP1498418A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 01/19/2005 | EP1498140A2 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1498124A2 The use of inhibitors of the renin-angiotensin system |
| 01/19/2005 | EP1498121A1 Use of specific cyclolignans |
| 01/19/2005 | EP1498118A1 Patch and process for producing the same |
| 01/19/2005 | EP1497436A1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolic disorders using such raav virons |
| 01/19/2005 | EP1497435A2 Placental derived stem cells and uses thereof |
| 01/19/2005 | EP1497425A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 01/19/2005 | EP1497419A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof |
| 01/19/2005 | EP1497334A2 Protein stabilisation using chaperone proteins |
| 01/19/2005 | EP1497306A1 Alternatively spliced nucleic acid molecules |
| 01/19/2005 | EP1497296A1 1,4 DIAZOCINO 7,8,1-hi INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 01/19/2005 | EP1497294A1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 01/19/2005 | EP1497288A1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament |
| 01/19/2005 | EP1497287A1 Quinolinone derivatives |
| 01/19/2005 | EP1497285A1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 01/19/2005 | EP1497279A2 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497271A1 Indane acetic acid derivatives and their use as pharmaceutical agents |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497265A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 01/19/2005 | EP1497019A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/19/2005 | EP1496940A2 Methods of treating diabetes using pde 11a inhibitors |
| 01/19/2005 | EP1496930A2 G-type peptides to ameliorate atherosclerosis |
| 01/19/2005 | EP1496929A1 Use of c5a receptor antagonist in the treatment of fibrosis |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496909A1 Combination therapy for the treatment of cancer |
| 01/19/2005 | EP1496907A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496900A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496896A1 Inhibitors of akt activity |
| 01/19/2005 | EP1496894A1 Angiogenesis inhibitors |
| 01/19/2005 | EP1496890A1 Substituted beta-aminoalcohols used as medicaments |
| 01/19/2005 | EP1496884A1 Association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 01/19/2005 | EP1496883A1 Method for treating ileus with an alpha-ketoalkanoic acid, ester or amide |
| 01/19/2005 | EP1496881A2 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 01/19/2005 | EP1496878A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 01/19/2005 | EP1496877A2 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 01/19/2005 | EP1496863A2 Preparation and use of a stable formulation of allosteric effector compounds |
| 01/19/2005 | EP1496857A1 Aerosol containing a particulate active substance |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1496834A2 High affinity integrin polypeptides and uses thereof |
| 01/19/2005 | EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/19/2005 | EP1392366A4 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 01/19/2005 | EP1208104B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 01/19/2005 | EP1140038B1 Transdermal drug delivery system |
| 01/19/2005 | EP1063228B1 Cycloalkene derivatives, process for producing the same, and use |
| 01/19/2005 | EP0941116B1 Use of vegf for the manufacture of a medicament for the treatment or prevention of intimal hyperplasia and delivery device |
| 01/19/2005 | EP0933995B8 Method of treating endothelial injury |
| 01/19/2005 | EP0784429B1 Therapeutic combinations of venous dilators and arterial dilators |
| 01/19/2005 | CN2671571Y Medicinal plaster for anus |
| 01/19/2005 | CN1568374A Method for identifying compounds modulating reverse cholesterol transport |
| 01/19/2005 | CN1568323A Activator for peroxisome proliferator-activated receptor delta |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568316A Activator for peroxisome proliferator-responsive receptor delta |
| 01/19/2005 | CN1568310A Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/19/2005 | CN1568308A Salts of guanidine derivatives and pharmaceutical preparations consisting thereof |
| 01/19/2005 | CN1568307A Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1568199A Drugs ameliorating hypo-HDL cholesterolemia |
| 01/19/2005 | CN1568198A Use of cd23 antagonists for the treatment of neoplastic disorders |
| 01/19/2005 | CN1568195A Peptide YY and peptide YY agonists for treatment of metabolic disorders |
| 01/19/2005 | CN1568194A Modulation of smooth muscle cell proliferation |
| 01/19/2005 | CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof |
| 01/19/2005 | CN1568186A Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage |
| 01/19/2005 | CN1568183A Citalopram for the treatment of elevated blood pressure |
| 01/19/2005 | CN1566356A Method for preparing earthworm bioactive peptide and earthworm biological micro-fertilizer and use thereof |
| 01/19/2005 | CN1566343A Method for making chitosan nanoparticle-pcDNA3.1-hVEGF gene complex |
| 01/19/2005 | CN1566326A Lactobacillus casei LC2W strain and its application in treatment of high blood pressure |
| 01/19/2005 | CN1566128A Sugar charcoal glycoside isoflavone compound containing alkane amine group and alkoxy substitution, process and uses thereof |
| 01/19/2005 | CN1566127A Novel flavonoids |
| 01/19/2005 | CN1566126A Novel natural drug effective region |
| 01/19/2005 | CN1566125A Scutellarin complex salt and preparing method for preparation thereof |
| 01/19/2005 | CN1566098A Isoquinoline compound, preparation method and application of salt thereof |
| 01/19/2005 | CN1566077A Algal ammonia acid and functions thereof |
| 01/19/2005 | CN1565619A Novel usage of soluble P-lectin and anthrax lethal toxin |
| 01/19/2005 | CN1565609A Chinese herbal medicine compositions and is usage |
| 01/19/2005 | CN1565606A Chinese drug with functions of regulating blood lipid and treating cardiovascular and cerebrovascular disease |
| 01/19/2005 | CN1565604A Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals , and clearing away toxin |
| 01/19/2005 | CN1565600A Chinese medicinal composition for treating hypertension |
| 01/19/2005 | CN1565599A Chinese drug injection formulation for dissolving cerebral thrombus |
| 01/19/2005 | CN1565580A Medicine for treating cerebral thrombosis and its preparing process |
| 01/19/2005 | CN1565577A Medicinal capsule of rhubarb horsetails and granule beetle and its preparation method |
| 01/19/2005 | CN1565569A Processing technique of Aconitum Carrnichaeli Debx |
| 01/19/2005 | CN1565564A Preparation method of |
| 01/19/2005 | CN1565548A Chinese drugs for treatment of coronary heart disease and angina pectoris |
| 01/19/2005 | CN1565542A Blood pressure reducing and blood fat removing healthy compositions |
| 01/19/2005 | CN1565540A Chinese traditional medicine for treating cardiac arrhythmia and its preparation method |
| 01/19/2005 | CN1565535A Manufacturing technique of freeze-dried wilsonii powder for injection |
| 01/19/2005 | CN1565531A Medicine for treating cerebral hemorrhage and its preparing method |
| 01/19/2005 | CN1565509A Hemorrhoid treating ointment |
| 01/19/2005 | CN1565497A Hypertension lowering and blood fat reducing tea and its preparation |
| 01/19/2005 | CN1565482A Hemorrhoid internal removing powder |
| 01/19/2005 | CN1565476A Iodine ion injection liquid |
| 01/19/2005 | CN1565472A Breviscapine slow release microsphere medicine formulation |